| Literature DB >> 17919769 |
Albiruni Ryan Abdul Razak1, Katy J Chatten, Andrew N Hughes.
Abstract
The role of second line treatment in malignant pleural mesothelioma (MPM) is currently undefined. We present four cases of patients who had durable responses from pemetrexed-based chemotherapy who were retreated with a similar regimen upon progression of their mesothelioma. This case series explores the possible role of retreatment with pemetrexed-based chemotherapy as a second line therapeutic option in MPM.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17919769 DOI： 10.1016/j.lungcan.2007.08.031
Source DB: PubMed Journal: Lung Cancer ISSN： 0169-5002 Impact factor: 5.705